Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zopocianine (OTL78) for Intraoperative Imaging of Prostate Cancer
NCT06849544Phase 2Completed
- Start
- Apr 2025
- Primary completion
- Jun 2026
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of zopocianine in prostate cancer (PCa). Started Apr 2025; status: completed.
02
Drugs
zopocianine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT06849544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06849544.